Company | Name | Exchange | Sector | Industry | Piotroski Score | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Upgrade to Pro+ | London | Technology | Software & IT Services | Upgrade to Pro+ | £55.93M | 8.2x | 0 | GBX 159 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Upgrade to Pro+ | London | Financial | Investment Banking & Investment Services | Upgrade to Pro+ | £2.55B | 3.7x | 0.03 | GBX 238 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.7% Upside | Upgrade to Pro+ | |
Upgrade to Pro+ | London | Basic Materials | Metals & Mining | Upgrade to Pro+ | £140.49M | 5.8x | 0.02 | GBX 186.22 | -4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32.9% Upside | Upgrade to Pro+ | |
Upgrade to Pro+ | London | Basic Materials | Metals & Mining | Upgrade to Pro+ | £316.60M | 3.1x | 0.01 | GBX 48.50 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.6% Downside | Upgrade to Pro+ | |
Upgrade to Pro+ | London | Healthcare | Biotechnology & Medical Research | Upgrade to Pro+ | £3.26B | 4.3x | 0 | GBX 4,641.24 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |